Pharmaceutical Lipid Formulations of Amphotericin B for the Treatment of Human Leishmaniasis

The first description of a skin lesion, “Delhi button” dates back to Cunningham (1885) who reported the presence, on tissue sections, of bodies of 12.6 μm x 8.8 μm, presumably parasitic macrophages, containing "nucleoid bodies" which he believed to be spores belonging to Mycetozoa. But the first to describe the Leishmania parasite was, in 1898, a young man Russian military surgeon, named Borowsky. He investigated the cause of the "Sart button" at the military hospital in Tashkent. This paper, through the analysis of the studies carried out over the years proposes a description of the different therapeutic strategies for the treatment of leishmaniasis (advantages and criticalities of the same) and in particular an analysis detailed description of Amphotericin B, its mechanisms of action and pharmaceutical formulations, especially liposomal ones.